Log in

Kane Biotech Stock Forecast, Price & News

+0.01 (+3.33 %)
(As of 09/17/2020 09:30 AM ET)
Today's Range
Now: C$0.16
50-Day Range
MA: C$0.16
52-Week Range
Now: C$0.16
Volume500 shs
Average Volume77,955 shs
Market CapitalizationC$16.84 million
P/E RatioN/A
Dividend YieldN/A
Kane Biotech Inc., a biotechnology company, researches, develops, and commercializes technologies and products that prevent and remove microbial biofilms worldwide. It develops pet oral care solutions under the StrixNB and bluestem trademarks; animal and human wound care solutions under the DispersinB trademark; medical device coatings under the Aledex trademark; and shampoo for dogs, cats, and horses under the Alosera trademark. The company was founded in 2001 and is based in Winnipeg, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.1Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.42 out of 5 stars

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesC$1.57 million
Cash FlowC$0.00 per share
Book ValueC$0.00 per share



Market CapC$16.84 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
+0.01 (+3.33 %)
(As of 09/17/2020 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KNE News and Ratings via Email

Sign-up to receive the latest news and ratings for KNE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Kane Biotech (CVE:KNE) Frequently Asked Questions

How has Kane Biotech's stock price been impacted by COVID-19?

Kane Biotech's stock was trading at C$0.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, KNE stock has decreased by 13.9% and is now trading at C$0.16.
View which stocks have been most impacted by COVID-19

When is Kane Biotech's next earnings date?

Kane Biotech is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Kane Biotech

Who are some of Kane Biotech's key competitors?

Who are Kane Biotech's key executives?

Kane Biotech's management team includes the following people:
  • Mr. Marc Edwards, Interim CEO & Director
  • Mr. Ray Dupuis, Chief Financial Officer
  • Mr. Mark Ahrens-Townsend, Advisor
  • Dr. Gordon Guay, Chief Scientific Officer & Member of Scientific Advisory Board
  • Mr. L. Michael Coutts, Director of Bus. Devel.

What is Kane Biotech's stock symbol?

Kane Biotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "KNE."

How do I buy shares of Kane Biotech?

Shares of KNE and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab.

What is Kane Biotech's stock price today?

One share of KNE stock can currently be purchased for approximately C$0.16.

How big of a company is Kane Biotech?

Kane Biotech has a market capitalization of C$16.84 million and generates C$1.57 million in revenue each year.

What is Kane Biotech's official website?

The official website for Kane Biotech is www.kanebiotech.com.

How can I contact Kane Biotech?

Kane Biotech's mailing address is 162-196 Innovation Dr, WINNIPEG, MB R3T 6C5, Canada. The company can be reached via phone at +1-204-4531301.

This page was last updated on 9/18/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.